Netcents Technology Inc. (NTTCF: OTCQB) | NetCents
Top 10 Most Recent News Articles
Posterity Health Boosts Network to Six New Markets
Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...
Continue Reading
California Exodus: Companies Flee Amid Wealth Tax Fears
Businesses Escaping the Golden State Proposition 40—the looming specter over California's business landscape. This so-called billionaire tax has stirred quite the storm, and from where I'm sitting, it's no surprise folks are heading for the exits. Cummings & Cummings Law reports a jaw-dropping 12-fold increase in companies scooting out of California and making a beeline...
Continue Reading
UP Fintech Faces Class Action Over Alleged Misconduct
UP Fintech: A Financial Storm Brews When it rains, it sure pours. Investors are finding themselves stuck in the middle of a squall as UP Fintech Holding Limited's legal troubles unfold. Robbins LLP, a shareholder rights law firm, has filed a class-action lawsuit targeting UP Fintech (NASDAQ:TIGR), and the lawsuit isn't just some casual fling—it digs deep into the...
Continue Reading
Webull Faces Class Action: Deadline Looms Dec 2026
Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...
Continue Reading
Real-World Study Shows Viable Use of Tarlatamab
Breaking New Ground in Cancer Care There's a shift happening in the realm of cancer treatment, and OneOncology's latest study on tarlatamab is right at the forefront. Bringing advanced therapies closer to home isn't just a pipe dream anymore. This real-world study, unveiled at the 2026 ESMO Congress, underscores that administering tarlatamab in outpatient settings might...
Continue Reading
Ferrovial's 2026 Growth: North America Drives Success
Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....
Continue Reading
Shira Goodman Joins APEI Board: New Direction?
A New Chapter for American Public Education Alright, sit tight because this one’s got layers. American Public Education, Inc. (Nasdaq: APEI) just shook up its board by bringing in Shira Goodman, the former CEO of Staples. This move isn't just swapping one name for another; it’s about bolstering leadership at a time when strategic decisions are pivotal. Who is Shira...
Continue Reading
New Era for Small Cell Lung Cancer: Breakthroughs & Challenges
Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...
Continue Reading
Lear Capital Hits $5 Billion Milestone: Trust or Hype?
A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...
Continue Reading
HDF and IOM Join Forces for Crisis Relief Efforts
New Partnership Navigates Humanitarian Complexities Alright, let's cut to the chase. Today, HDF and IOM threw another log on the fire powering humanitarian aid. These big names just inked a Memorandum of Understanding in Geneva, emphasizing their goal of streamlined cooperation to counter crises in Sudan and Yemen. Now, if you're curious about the weight of such...
Continue ReadingTop 5 Most Recently Viewed Articles
CompTIA's Cybersecurity Viability Session at TechNet Augusta
CompTIA's Upcoming Session at TechNet Augusta Conference CompTIA is set to present a significant session at the upcoming TechNet Augusta conference, focusing on how people, data, and artificial intelligence (AI) can come together to enhance the readiness of cybersecurity. This session is an integral part of the CompTIA Learning Solutions Series, scheduled for a day...
Continue Reading
Laura Mercier Launches on Amazon: A New Era of Beauty
Laura Mercier Launches on Amazon Premium Beauty Award-winning beauty brand Laura Mercier has officially launched on the Amazon U.S. Premium Beauty Store, enhancing accessibility to high-quality beauty products. Renowned for its artistry-inspired makeup and skincare lines, Laura Mercier is now joining forces with Amazon, making it easier for beauty enthusiasts everywhere...
Continue Reading
Truist Adjusts Merck's Stock Target Amid Acquisition Insights
Truist Adjusts Merck's Price Target Recently, Truist Securities revised its price target for Merck & Co., Inc. (NYSE:MRK) from $143.00 down to $132.00. Despite this adjustment, they continue to maintain a Buy rating for the stock, showcasing their confidence in its long-term potential. Impact of the Recent Acquisition This downgrade comes on the heels of Merck's...
Continue Reading
Xilio Therapeutics Expands Team with Stock Options Grant
Xilio Therapeutics Expands Team with Stock Options Grant Xilio Therapeutics, Inc. (Nasdaq: XLO), a cutting-edge biotechnology firm focused on developing tumor-activated immuno-oncology therapies, is making significant strides in its mission to support those living with cancer. In an exciting development, the company has announced the granting of a non-qualified stock...
Continue Reading
Crunching the Numbers: Navigating Portugal’s Mortgage Landscape for Smart Investments
For the analytical investor, every property acquisition begins with the numbers. In Portugal, a market celebrated for its steady growth and robust financial incentives, understanding mortgage dynamics is essential to making sound investment decisions. You might find that a deep dive into Portugal’s mortgage landscape reveals both challenges and substantial...
Continue Reading